Soluble epoxide hydrolase and ischemic cardiomyopathy

International Journal of Cardiology
Ting-Ting ZhaoShui-Ping Zhao


The development of cardiovascular disease has been linked to lowered levels of epoxyeicosatrienoic acids (EETs) in the cardiovascular system. Ischemic cardiomyopathy is caused by atherosclerotic lesions in multi-coronary arteries especially diffusive lesions, which can lead to severe myocardial dysfunction, heart enlargement, heart failure, or arrhythmia, and so on. The EETs are metabolized by the soluble epoxide hydrolase (sEH) encoded by the EPHX2 gene that has several known polymorphisms. The EPHX2 gene polymorphism is associated with sEH catalytic activity and various cardiovascular diseases. sEH is distributed in a variety of organs and tissues and regulated by multiple factors. Research in the area has led to the presence of multiple powerful soluble epoxide hydrolase inhibitors (sEHIs), whose molecular structure and function has been optimized gradually. sEHIs increase EETs' concentration by inhibiting hydration of EETs into their corresponding vicinal diols. EETs are important signaling molecules and known as endothelium-derived hyperpolarizing factors (EDHF). sEHIs have been developed for their ability to prevent atherosclerosis, dilate the coronary artery, promote angiogenesis, ameliorate postischemic recovery of hear...Continue Reading


Mar 1, 1992·Human & Experimental Toxicology·S PetruzzelliC Giuntini
Jan 1, 1986·Advances in Experimental Medicine and Biology·F OeschW Wörner
Feb 1, 1980·Biochemical Pharmacology·S S Gill, B D Hammock
Sep 26, 2000·The Journal of Biological Chemistry·C J SinalF J Gonzalez
Jan 13, 2001·Chemico-biological Interactions·A J Fretland, C J Omiecinski
Oct 22, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Xiang FangArthur A Spector
Feb 8, 2003·Proceedings of the National Academy of Sciences of the United States of America·John W NewmanBruce D Hammock
Jul 19, 2003·Molecular Pharmacology·Beata D Przybyla-ZawislakDavid F Grant
Nov 26, 2003·Progress in Lipid Research·Arthur A SpectorNeal L Weintraub
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·Christophe Morisseau, Bruce D Hammock
Jul 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·Kara R SchmelzerBruce D Hammock
Nov 1, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Brandon T LarsenDavid D Gutterman
Nov 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Yi LiuJohn Y-J Shyy
Dec 7, 2005·Circulation·Scott D SolomonUNKNOWN Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators
Jul 22, 2006·Circulation Research·John M SeubertDarryl C Zeldin
Sep 22, 2006·American Journal of Physiology. Cell Physiology·Arthur A Spector, Andrew W Norris
Nov 30, 2006·Proceedings of the National Academy of Sciences of the United States of America·Danyan XuNipavan Chiamvimonvat
Dec 14, 2006·Prostaglandins & Other Lipid Mediators·Bora InceogluBruce D Hammock
May 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ding AiYi Zhu
Apr 3, 2008·Pest Management Science·Christophe Morisseau, Bruce D Hammock
Apr 29, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Garrett J GrossKasem Nithipatikom
Jun 10, 2008·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Kathryn P BurdonDonald W Bowden
Sep 9, 2008·Journal of Pharmacological Sciences·Sachiko SuzukiSusumu Imaoka
Oct 7, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Atsuko MotokiDonna M Van Winkle
Oct 18, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Hantz C HerculeMaik Gollasch
Nov 1, 2008·Journal of Molecular and Cellular Cardiology·S N BatchuJ M Seubert
Nov 1, 2008·The Journal of Biological Chemistry·Ahmed E EnayetAllahDavid F Grant

❮ Previous
Next ❯


Oct 2, 2012·Annual Review of Pharmacology and Toxicology·Christophe Morisseau, Bruce D Hammock
Dec 7, 2018·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Alexey V PolonikovMaria A Solodilova
Sep 26, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·In Sook ChoYoung Ho Kim
Feb 12, 2021·International Journal of Molecular Sciences·K Lockhart JamiesonJohn M Seubert
Mar 16, 2021·Frontiers in Physiology·Jinsheng Lai, Chen Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.


Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Cardiovascular Homeostasis

Cardiovascular regulation and homeostasis is important in maintaining health and dysfunction may lead to cardiovascular diseases. Nitric oxide and vascular endothelium are one of many molecules involved in the homeostatic mechanism. Here is the latest research on cardiovascular homeostasis.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.


Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.